Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Queensland Health
McKinsey
Julphar
Dow
Teva
Fish and Richardson
Chubb
Moodys

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074557

« Back to Dashboard

NDA 074557 describes CHOLESTYRAMINE, which is a drug marketed by Ani Pharms Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Teva, Teva Pharms, and Zydus Pharms Usa Inc, and is included in ten NDAs. It is available from two suppliers. Additional details are available on the CHOLESTYRAMINE profile page.

The generic ingredient in CHOLESTYRAMINE is cholestyramine. There are eight drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the cholestyramine profile page.
Summary for 074557
Tradename:CHOLESTYRAMINE
Applicant:Sandoz
Ingredient:cholestyramine
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074557
Mechanism of ActionBile-acid Binding Activity
Suppliers and Packaging for NDA: 074557
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CHOLESTYRAMINE cholestyramine POWDER;ORAL 074557 ANDA Eon Labs, Inc. 0185-0940 N 0185-0940-98
CHOLESTYRAMINE cholestyramine POWDER;ORAL 074557 ANDA Eon Labs, Inc. 0185-0940 N 0185-0940-97

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/PACKET
Approval Date:Aug 15, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:POWDER;ORALStrengthEQ 4GM RESIN/SCOOPFUL
Approval Date:Aug 15, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Fish and Richardson
US Army
Julphar
Moodys
Teva
Federal Trade Commission
Express Scripts
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.